Study of Peptide Vaccination With Tumor Associated Antigens Mixed With Montanide in Patients With CNS Tumors
NCT00935545
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
15
Enrollment
OTHER
Sponsor class
Conditions
Tumors, Central Nervous System
Interventions
BIOLOGICAL:
Montanide
Sponsor
NYU Langone Health